DNA synthesis is not necessary for osteoclastic responses to parathyroid hormone in cultured fetal rat long bones.
INTRODUCTION
Osteoclasts are believed to be the principal cellular mediator of bone resorption (1) (2) (3) (4) . These cells are multinucleated but have never been shown to multiply by cell division. Instead, they increase their size and number in response to resorptive stimuli through fusion of a mononuclear precursor cell into either new or existing osteoclasts (1) (2) (3) (4) . While there is good evidence that the osteoclast precursor cell is derived from a hematopoietic stem cell (5-7), little is known about the effect of resorptive stimuli on the replication of this precursor or the relationship of cell replication to bone resorption. Parathyroid hormone (PTH)' is an important stimulator of bone resorption both in vivo and in vitro, and increases the number of osteoclasts in bone (8) (9) (10) . PTH also increases DNA synthesis in bone cells (2, 11, 12, 13) . However, definitive evidence demonstrating that the cells that replicate in response to PTH also differentiate into osteoclast precursor cells is lacking. We therefore examined an inhibitor of DNA synthesis, hydroxyurea (HU) (14) , for its effects on fetal rat bone organ cultures to determine if PTH required a mitogenic response to mediate its effects on resorption and osteoclast formation.
METHODS
Culture techniques. Our method of fetal rat bone organ culture has been described in detail elsewhere (15, 16 ,. Briefly, 19-d fetal rat forelimb bones labeled in utero with 4 Ca were dissected free of surrounding muscle, cartilage, and fibrous tissue, and cultured in 0. 5 After 24, 48, and 120 h, release of 45Ca from unstimulated cultures was inhibited by 1 mM HU (Tables III  and IV) . After 24 h, 100 nM PTH stimulated both 45Ca release and [3H]thymidine incorporation into the bones (Table IV) . HU significantly decreased the magnitude of the 24-h resorptive response to 100 nM PTH by >40% and the incorporation of [3H]thymidine into the cold acid insoluble fraction by >90%. However, because HU decreased both unstimulated and PTH-stimulated resorption equally, it did not alter the ratio of PTH- 24 and 48 h (Table IV) . As with 100 nM PTH, after 24 h, the decrease in the resorptive response with 3 nM PTH was proportional to the decrease seen in unstimulated resorption with HU alone. At all other time points and concentrations of PTH, the resorptive response with HU was equal to or greater than that seen in bone cultured without HU. In fact, because HU decreased unstimulated resorption, we could detect significant resorptive responses at lower PTH concentrations when HU was present in the medium.
At concentrations below 100 nM, there was no effect of PTH on [3H]thymidine uptake into either the cold acid extractable or the cold acid insoluble fractions (data not shown).
After 48 h, 100 nM PTH increased the number of osteoclasts per bone section by twofold, regardless of whether or not HU was present in the cultures (Table  V) . There was no significant difference between HUtreated groups and control bones in the number of nuclei contained in osteoclasts (Table V) , although the of osteoclast nuclei containing label that was greater than in controls. This result may indicate that some replication of osteoclast precursors occurred in bones treated with PTH and HU. However, the actual number of labeled nuclei detected in either HU-treated group was small and not significantly different, implying that the majority of nuclei found in osteoclasts of bones treated with either HU or HU + PTH derived from precursors that had not recently divided.
DISCUSSION
The mechanism by which HU inhibits DNA synthesis in cells has been well studied and is believed to result from an action of this agent on the enzyme ribonucleotide reductase (23) (24) (25) . In cell cultures. this effect is rapid and occurs within 30 min. In our studies, HU inhibited [3H]thymidine incorporation into DNA maximally after 6 h, the earliest time point we examined. HU can also have inhibitory effects on cellular RNA and protein synthesis (23) . However, we doubt these latter actions contributed to the decrease in resorption seen in either unstimulated cultures or cultures treated with 100 nM PTH for 24 h because, at other concentrations of PTH, 1 mM HU either had no effect or enhanced 45Ca release, and because HU did not block the increase in the number of osteoclasts present in bones treated with 100 nM PTH. conclude that in fetal rat bone cultures these actions of PTH do not require the replication of osteoclast precursor cells. Rather, it appears that PTH can activate the available pool of osteoclast precursor cells to fuse into new osteoclasts through a process that is independent of cell replication. Further evidence that PTH activates preexisting osteoclasts to resorb and causes increased fusion of osteoclast precursors into preexisting osteoclasts comes from previous studies of bone cultures which have shown PTH to rapidly activate existing osteoclasts (10) and to form new osteoclasts before the incorporation of [3H]thymidine into osteoclast nuclei (26) .
In agreement with our results, studies of the effects of DNA synthesis inhibitors on myoblasts have shown that these cells are also capable of becoming multinucleated when cell replication is inhibited (27) . Recently, Kreiger et al. (28) found that x-irradiation did not inhibit PTH from stimulated calcium release from newborn mouse calvarial cultures or from increasing osteoclast number after 48 h of culture. However, in contrast to our results, they did not find x-irradiation to decrease unstimulated levels of bone resorption. The reason for this difference between our results and theirs is unknown, but may result from species differences, differences between the action of HU and x-irradiation on bone, or differences in the technique used to measure bone resorption.
In contrast to previous studies (10), we failed to detect a change in the number of nuclei in osteoclasts after PTH treatment. However, this response is small and has not always been found by others (29) . If changes in the number of nuclei per osteoclast do relate to bone resorbing activity, it is possible that the decrease in 45Ca release seen after 24 h of culture in bones treated with 100 nM PTH and HU was related to the decreased number of nuclei present in the osteoclasts of these bones. It is less likely that the inhibition of 45Ca release seen in bones treated with HU alone is related to changes in the number of osteoclasts per bone or nuclei per osteoclast since differences in these latters' parameter were not significant between this group and control. Hence, an unknown mechanism appears responsible for the decrease in 45Ca release seen in unstimulated HU-treated bones, which may or may not be related to the decrease in cell replication caused by HU. Because 
